The Influence of Age on Dexmedetomidine Pharmacodynamic

Status Completed

Clinical Trial Summary

Dexmedetomidine(DEX) is a novel , highly selective α2 adrenergic receptor agonists , and its selectivity for α2 receptor is 1600 times higher than α1.It also could provide dose-dependent sedation , analgesia , anti-anxiety and inhibition of sympathetic nerves and other effects .At earlier time It was approved by the FDA only for short-time sedation during mechanical ventilation of adult patients (<24h) in ICU. Because of its minimal impact on the respiratory , currently it was more and more widely used to sedate patients undergoing regional anesthesia.Many anesthetic pharmacokinetics and pharmacodynamics are often affected by age and gender,such as the drug sensitivity of propofol and remifentanil is increased with age,while the current study also demonstrated that gender may influence the sedate efficacy of propofol and the sensitivity of muscle loose of rocuronium. Current studies with regard to the effects of age and gender on dexmedetomidine pharmacodynamic are rare. The study is aim to explore the right DEX dose of different Age of patients to produce suitable sedation.Dexmedetomidine be used in patients with combined spinal and epidural anesthesia for sedation,which is monitored by the BIS,during the operation.The relation between BIS values and the depth of sedation for patients is also investigated.

Clinical Trial Description

120 patients scheduled to undergo lower extremity surgery were included in one of three groups. Determination of median effective (ED50) doses was performed by the Dixon and Mood up-and-down method. Initial doses was 1μg/kg, with dose adjustment intervals of 0.05μg/kg, in the youth,and middle-aged group. The initial doses of DEX was 0.7 μg/kg,also with dose adjustment intervals of 0.05μg/kg.Sedative efficacy was defined as an OAA/S of ≤2, or an OAA/S of 3 but with an BIS value of ≤46, 26 min after the beginning of drug administration. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Spinal Anesthesia

Clinical Trial Details

NCT number	NCT02099253
Study type	Interventional
Source	Guangzhou General Hospital of Guangzhou Military Command
Contact
Status	Completed
Phase	Phase 4
Start date	March 2014
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02565303` - Minimum Effective Dose of Ropivacaine for Spinal Anesthesia for Cesarean Delivery	N/A
Recruiting	`NCT03248817` - Phenylephrine Infusion in Cesarean Delivery	Phase 4
Completed	`NCT02840006` - Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass	Phase 4
Completed	`NCT01624844` - Predictive Value of Ultrasound Measurement of the Dural Sac Volume on the Sensory Level in Spinal Anesthesia	N/A
Recruiting	`NCT00974961` - Levobupivacaine on Heart Rate Variability (HRV) in Spinal Anesthesia	Phase 4
Recruiting	`NCT00492453` - Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy	N/A
Completed	`NCT05549011` - PENG vs SIFI Block for Positioning Pain During Spinal Anesthesia
Completed	`NCT03805503` - Chloroprocaine for Inguinal Herniorrhaphy	Phase 4
Completed	`NCT03775655` - Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section	Phase 2/Phase 3
Completed	`NCT03199170` - Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section	N/A
Completed	`NCT03302039` - Three Protocols for Phenylephrine Administration in Cesarean Delivery	Phase 4
Not yet recruiting	`NCT05063292` - Effect of Prewarming On Skin Temperature Changes	N/A
Not yet recruiting	`NCT05583214` - Evaluating the Effectiveness of Ondansetron Versus Dexamethasone Versus Placebo for the Control of Intraoperative Nausea and Vomiting in Patients Undergoing Lower-segment Caesarean Section Under Spinal Anesthesia	Phase 4
Recruiting	`NCT02937792` - Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section	N/A
Recruiting	`NCT01415284` - ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia	Phase 4
Completed	`NCT00537472` - Low Dose Spinal Bupivacaine for Total Knee Replacement and Recovery Room Wait Time	N/A
Completed	`NCT05548985` - Midodrine for Prophylaxis Against Post Spinal Hypotension in Elderly Population	N/A
Completed	`NCT03322098` - Effect of Atropine or Glycopyrrolate on the Prevention of Bradycardia During Sedation Using Dexmedetomidine in Geriatric Patients Undergoing Total Knee Replacement Under Spinal Anesthesia	N/A
Recruiting	`NCT04598061` - IV Dexmedetomidine as Spinal Anesthesia Adjuvant in Infants
Completed	`NCT04083768` - Effect of Different Left Lateral Table Tilt for Elective Cesarean Delivery Under Spinal Anesthesia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.